TODAY'S HEADLINES

Gilead promises generic versions of new hep B drug

While hepatitis C drugs have often been criticized for their high prices, Gilead Sciences promises generic versions of its drug for chronic hepatitis B virus, which was just approved by FDA. Read more

Breakthrough lymphoma drug on the horizon

FDA recently granted breakthrough therapy designation to brentuximab vedotin (Adcetris) to treat patients with the most common subtypes of lymphoma. Read more

CONTINUING PHARMACY EDUCATION

Addressing unique medication adherence issues for patients with schizophrenia

This month's CE activity, "Addressing unique medication adherence issues for patients with schizophrenia," is open for pharmacists and pharmacy technicians.
The goal of this activity is to educate pharmacists and pharmacy technicians in how to best assist patients in the use of medications to treat schizophrenia.
Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

First olmesartan generics approved for hypertension

In a big move for patients who take blood pressure medication on a regular basis, FDA recently approved the first generic versions of 4 drugs that contain the blood pressure-lowering medication olmesartan medoxomil (Benicar). Read more

November 16, 2016

Related Articles

Top 5 things to know about new lymphoma drug

Cheaper hep C drug enters competitive market